Explore our sister journals here.

Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 22.12.15 in Vol 1, No 2 (2015): Jul-Dec

This paper is in the following e-collection/theme issue:

Works citing "Direct-to-Patient Research: Piloting a New Approach to Understanding Drug Safety During Pregnancy"

Nancy A Dreyer, Stella CF Blackburn, Shahrul Mt-Isa, Jonathan L Richardson, Simon Thomas, Maja Laursen, Priscilla Zetstra-van der Woude, Anna Jamry-Dziurla, Valerie Hliva, Alison Bourke, Lolkje de Jong-van den Berg

JMIR Public Health Surveill 2015 (Dec 22); 1(2):e22 

According to Crossref, the following articles are citing this article (DOI 10.2196/publichealth.4939):

(note that this is only a small subset of citations)

  1. Richardson JL, Stephens S, Thomas SHL, Jamry-Dziurla A, de Jong-van den Berg L, Zetstra - van der Woude P, Laursen M, Hliva V, Mt-Isa S, Bourke A, Dreyer NA, Blackburn SC. An International Study of the Ability and Cost-Effectiveness of Advertising Methods to Facilitate Study Participant Self-Enrolment Into a Pilot Pharmacovigilance Study During Early Pregnancy. JMIR Public Health and Surveillance 2016;2(1):e13
    CrossRef
  2. Laursen M, Hallgreen CE, Dreyer N, Bourke A, Mt‐Isa S, Blackburn S. Comparison of electronic self‐reported prescription medication use during pregnancy with the national prescription register in Denmark. Pharmacoepidemiology and Drug Safety 2020;29(3):328
    CrossRef
  3. Ley C, Willis L, de la Luz Sanchez M, Parsonnet J, Fischer F. Recall accuracy of weekly automated surveys of health care utilization and infectious disease symptoms among infants over the first year of life. PLOS ONE 2019;14(12):e0226623
    CrossRef
  4. Yates LM, Thomas SH. Prescribing medicines in pregnancy. Medicine 2016;44(7):438
    CrossRef
  5. Koehn LM, Huang Y, Habgood MD, Kysenius K, Crouch PJ, Dziegielewska KM, Saunders NR. Effects of paracetamol (acetaminophen) on gene expression and permeability properties of the rat placenta and fetal brain. F1000Research 2020;9:573
    CrossRef
  6. . Advancing regulatory science, advancing regulatory practice. Pharmacoepidemiology and Drug Safety 2017;26(6):722
    CrossRef
  7. Koehn LM, Huang Y, Habgood MD, Kysenius K, Crouch PJ, Dziegielewska KM, Saunders NR. Effects of paracetamol (acetaminophen) on gene expression and permeability properties of the rat placenta and fetal brain. F1000Research 2020;9:573
    CrossRef
  8. Jongen PJ, Kremer IE, Hristodorova E, Evers SM, Kool A, van Noort EM, Hiligsmann M. Adherence to Web-Based Self-Assessments in Long-Term Direct-to-Patient Research: Two-Year Study of Multiple Sclerosis Patients. Journal of Medical Internet Research 2017;19(7):e249
    CrossRef
  9. Dreyer NA, Rodriguez AM. The fast route to evidence development for value in healthcare. Current Medical Research and Opinion 2016;32(10):1697
    CrossRef
  10. Dreyer NA, Hall M, Christian JB. Modernizing Regulatory Evidence with Trials and Real-World Studies. Therapeutic Innovation & Regulatory Science 2020;54(5):1112
    CrossRef
  11. Lupattelli A, Spigset O, Nordeng H. Learning the effects of psychotropic drugs during pregnancy using real-world safety data: a paradigm shift toward modern pharmacovigilance. International Journal of Clinical Pharmacy 2018;40(4):783
    CrossRef
  12. Dreyer NA, Reynolds M, DeFilippo Mack C, Brinkley E, Petruski-Ivleva N, Hawaldar K, Toovey S, Morris J. Self-reported symptoms from exposure to Covid-19 provide support to clinical diagnosis, triage and prognosis: An exploratory analysis. Travel Medicine and Infectious Disease 2020;38:101909
    CrossRef
  13. Dreyer N, Petruski-Ivleva N, Albert L, Mohamed D, Brinkley E, Reynolds M, Toovey S. Identification of a Vulnerable Group for Post-Acute Sequelae of SARS-CoV-2 (PASC): People with Autoimmune Diseases Recover More Slowly from COVID-19. International Journal of General Medicine 2021;Volume 14:3941
    CrossRef
  14. Dreyer N, Reynolds MW, Albert L, Brinkley E, Kwon T, Mack C, Toovey S. How frequent are acute reactions to COVID-19 vaccination and who is at risk?. Vaccine 2022;40(12):1904
    CrossRef
  15. Dolk H, Damase‐Michel C, Morris JK, Loane M. COVID‐19 in pregnancy—what study designs can we use to assess the risk of congenital anomalies in relation to COVID‐19 disease, treatment and vaccination?. Paediatric and Perinatal Epidemiology 2022;36(4):493
    CrossRef
  16. Reynolds MW, Xie Y, Knuth KB, Mack CD, Brinkley E, Toovey S, Dreyer NA. COVID-19 Vaccination Breakthrough Infections in a Real-World Setting: Using Community Reporters to Evaluate Vaccine Effectiveness. Infection and Drug Resistance 2022;Volume 15:5167
    CrossRef
  17. Richardson JL, Moore A, Bromley RL, Stellfeld M, Geissbühler Y, Bluett-Duncan M, Winterfeld U, Favre G, Alexe A, Oliver AM, van Rijt-Weetink YRJ, Hodson KK, Rezaallah B, van Puijenbroek EP, Lewis DJ, Yates LM. Core Data Elements for Pregnancy Pharmacovigilance Studies Using Primary Source Data Collection Methods: Recommendations from the IMI ConcePTION Project. Drug Safety 2023;46(5):479
    CrossRef
  18. Largent J, Xie Y, Knuth KB, Toovey S, Reynolds MW, Brinkley E, Mack CD, Dreyer NA. Cognitive and other neuropsychiatric symptoms in COVID-19: analysis of person-generated longitudinal health data from a community-based registry. BMJ Open 2023;13(6):e069118
    CrossRef
  19. Dreyer NA, Knuth KB, Xie Y, Reynolds MW, Mack CD. COVID-19 Vaccination Reactions and Risk of Breakthrough Infections Among People With Diabetes: Cohort Study Derived From Community Reporters. JMIR Diabetes 2024;9:e45536
    CrossRef

According to Crossref, the following books are citing this article (DOI 10.2196/publichealth.4939):

  1. Dreyer NA, Macedo AF, Velentgas P. Pharmacoepidemiology. 2019. :342
    CrossRef
  2. . Textbook of Pharmacoepidemiology. 2021. :192
    CrossRef